← Back to Search

Dietary Supplement

Curcumin, Omega-3 and Vitamin-D (COD) for Healthy Subjects (PASCOD Trial)

N/A
Waitlist Available
Led By Liam O'Neil, MD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 28
Awards & highlights

PASCOD Trial Summary

This trial will help us understand if it's safe to take curcumin, omega-3, and vitamin D together and if there are any side effects of taking them in this combination.

PASCOD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-reported Side Effects due to Supplements
Secondary outcome measures
Supplementation adherence
Other outcome measures
Alanine transaminase (ALT)
Albumin
Alkaline Phosphatase (ALK)
+34 more

PASCOD Trial Design

1Treatment groups
Experimental Treatment
Group I: Curcumin, Omega-3 and Vitamin-D (COD)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Curcumin, Omega-3 and Vitamin-D (COD)
2022
N/A
~50

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,472 Total Patients Enrolled
Liam O'Neil, MDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial offer participation to individuals over 45 years of age?

"Patients that desire to be part of this trial must fall within the age bracket 18-49. Additionally, there are 50 trials for minors under 18 and 371 for those above 65 years old."

Answered by AI

Is there an ongoing recruitment phase for this trial?

"Affirmative, the information on clinicaltrials.gov indicates that this medical trial is actively recruiting participants. It was initially published on July 11th 2022 and has since been revised. Currently, 20 individuals are sought from a single location to partake in the study."

Answered by AI

How many participants are being studied in this research project?

"Affirmative. According to clinicaltrials.gov, this experiment is currently enrolling research subjects and was initially listed on 11th July 2022 with the latest edit being made on 10th August 2022. In total, 20 people are needed from one medical facility for this trial."

Answered by AI

Am I qualified to partake in this research endeavor?

"This trial is looking for 20 healthy individuals between 18 and 49 years of age who meet the following specific criteria: BMI within the range of 18.5 - 34.9 (kg/m2), clinically acceptable laboratory results, two-doses of COVID-19 vaccine with 4 weeks inbetween dosing dates, ability to read and understand English consent documents, have contact information including telephone number, email address and mailing address, female participants must use effective contraception during trial period, are employees or students at a relevant medical centre willing to comply with all protocol requirements and not taking any vitamin d or Omega 3 supplements prior to enrolment."

Answered by AI

Who else is applying?

What state do they live in?
New Mexico
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~18 spots leftby Apr 2025